APA (7th ed.) Citation

D, A., S, M., P, Z., MA, A., Y, Z., & I, K. (2025). Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy. Cardiovascular drugs and therapy, 39(6), 1567. https://doi.org/10.1007/s10557-024-07652-3

Chicago Style (17th ed.) Citation

D, Alijanzadeh, Moghim S, Zarand P, Akbarzadeh MA, Zarinfar Y, and Khaheshi I. "Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy." Cardiovascular Drugs and Therapy 39, no. 6 (2025): 1567. https://doi.org/10.1007/s10557-024-07652-3.

MLA (9th ed.) Citation

D, Alijanzadeh, et al. "Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy." Cardiovascular Drugs and Therapy, vol. 39, no. 6, 2025, p. 1567, https://doi.org/10.1007/s10557-024-07652-3.